2014•European Journal of AnaesthesiologyRequires access

A specific antidote (Idarucizumab) to dabigatran reduces blood loss and improves coagulopathy in a dabigatran- and traumainduced bleeding model in pigs

Oliver Grottke, Markus Honickel, Joanne van Ryn, Hugo Ten Cate, Rolf Rossaint, Henri M.H. Spronk

Open publisher page 1 citations

Abstract

Grottke, O.1; Honickel, M.1; van Ryn, J.2; ten Cate, H.3; Rossaint, R.1; Spronk, H.3 Author Information

About this research paper

What this paper is about

Grottke, O.1; Honickel, M.1; van Ryn, J.2; ten Cate, H.3; Rossaint, R.1; Spronk, H.3 Author Information

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Grottke, O.1; Honickel, M.1; van Ryn, J.2; ten Cate, H.3; Rossaint, R.1; Spronk, H.3 Author Information

Key concepts: Dabigatran, Medicine, Idarucizumab, Antidote, Coagulopathy, Blood loss, Anesthesia, Direct thrombin inhibitor

Back to paper search Browse research topics Original source

A specific antidote (Idarucizumab) to dabigatran reduces blood loss and improves coagulopathy in a dabigatran- and traumainduced bleeding model in pigs — Research Paper | ScholarLens

A specific antidote (Idarucizumab) to dabigatran reduces blood loss and improves coagulopathy in a dabigatran- and traumainduced bleeding model in pigs

About this research paper

What this paper is about

Why it matters

Key contribution

Method / approach

Main findings

Limitations

Applications

Available abstract

Related papers